NCT02309385 - Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 3, 2017

Study Completion Date

March 3, 2017

Conditions

Non-Infectious Anterior Uveitis

Interventions

DRUG

8% Dexamethasone Sodium Phosphate - Visulex

DRUG

15% Dexamethasone Sodium Phosphate - Visulex

DRUG

Prednisolone Acetate (1%) Eye Drops

Trial Locations (6)

Charlotte Eye, Ear, Nose, and Throat Associates, Charlotte

Bergstrom Eye Research, Fargo

Retina and Uveitis Consultants of Texas, San Antonio

B-Berger and Associates, Austin

Moran Eye Center, University of Utah, Salt Lake City

Massachusetts Eye Research and Surgery Institution (MERSI), Cambridge